Related references
Note: Only part of the references are listed.Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension
Yuichi Tamura et al.
CIRCULATION JOURNAL (2018)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension
Wook-Jin Chung et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
REVEAL: a contemporary US pulmonary arterial hypertension registry
M. D. McGoon et al.
EUROPEAN RESPIRATORY REVIEW (2012)
The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States How REVEAL Differs From Historic and Non-US Contemporary Registries
Adaani E. Frost et al.
CHEST (2011)
Treatment of pulmonary arterial hypertension with targeted therapies
Dermot S. O'Callaghan et al.
NATURE REVIEWS CARDIOLOGY (2011)
Pulmonary Arterial Hypertension Baseline Characteristics From the REVEAL Registry
David B. Badesch et al.
CHEST (2010)
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Marc Humbert et al.
CIRCULATION (2010)
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
M. Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial (vol 149, pg 521, 2008)
G. Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2009)
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial
Gerald Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2008)
Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure
Gabriele Tumminello et al.
EUROPEAN HEART JOURNAL (2007)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
S Provencher et al.
EUROPEAN HEART JOURNAL (2006)
Screening, early detection, and diagnosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
M McGoon et al.
CHEST (2004)
Prognosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
VV McLaughlin et al.
CHEST (2004)
Clinical classification of pulmonary hypertension
G Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Mechanisms of disease: Pulmonary arterial hypertension
HW Farber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Survival in primary pulmonary hypertension - The impact of epoprostenol therapy
VV McLaughlin et al.
CIRCULATION (2002)
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension -: Prognostic factors and survival
O Sitbon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Medical therapy of pulmonary hypertension - An overview of treatment and goals
RJ Barst
CLINICS IN CHEST MEDICINE (2001)
Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
S Ghio et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)